Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fox Group has rapidly grown into a leading provider of aesthetic pharmaceuticals, devices, and training services. Its exclusive product portfolio includes dermal fillers like REVOLAX, skin boosters such as Seventy Hyal 2000, polynucleotide injectables like Vitaran/Nucleofill, PLLA-based fillers like aesPlla®, and the OVEO plasma pen. The company operates both as a distributor/wholesaler to clinics and through its own e-commerce platforms. It also provides accredited practitioner training via its Fox Academy division. No clinical trial data or traditional pharma pipeline exists; all products are CE/CA marked for safety where required.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fox Group.